2015, Bitler BG, Fatkhutdinov N, Zhang R. Potential therapeutic targets in ARID1A-mutated cancers. Expert Opin Ther Targets. England; 2015;19(11):1419?22.
2017, Karakashev S., Zhu H., Yokoyama Y. BET bromodomain inhibition synergizes with PARP inhibitor in epithelial ovarian cancer / S. Karakashev, H. Zhu, Y. Yokoyama, B. Zhao, N. Fatkhutdinov, A. Kossenkov, A. Wilson, F Simpkins, D. Spiecher, D. Khabele, B. Bitler & R Zhang // Cell Reports.-2017.-21(12) P. 3398-3405
2017, Wu S. Harnessing mutual exclusivity between TP53 and ARID1A mutations // S. Wu, N. Fatkhutdinov, R. Zhang // Cell cycle-2017.-16(24) P. 2313-2314
Sitemap
